Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-174

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 25021-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dap01 0014 01

Dap01 0014 01
Chemical structure of daptomycin depicted in a molecular diagram showing atoms and bonds typical of the compound.*
FDA Label Image

Dap01 0014 02

Dap01 0014 02
Label for Daptomycin injection, 500 mg per vial, lyophilized powder for intravenous use. The label states the product must be refrigerated and is a single-dose vial. It is manufactured by Sagent Pharmaceuticals and includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.